LFA-1

Overview

LFA-1 (αLβ2, CD11a/CD18, encoded by Itgal and Itgb2) is a β2 integrin whose ligand is ICAM-1. With VLA-4 it forms the wiki’s first and only adhesion mechanism: the pair physically retains T-bet⁺CD11c⁺ B cells at the splenic marginal zone as infection resolves.

This matters beyond cell biology. Because retention is active and can be reversed within hours, circulating frequency of these cells may partly reflect retention failure rather than pool size — a direct caution for any study, including a dengue pilot, that measures them in blood.

The blockade experiment cannot attribute the effect to LFA-1 specifically. The two integrins were blocked together in the single experiment that demonstrates the mechanism, so the wiki holds them as separate pages carrying a shared result, not as one mechanism — they have different ligands (ICAM-1 vs VCAM-1), different genes, and VLA-4 additionally carries a bone-marrow residency finding that does not apply here. (Merge considered and declined 2026-08-28 — see state.md Decisions.)

Note that LFA-1’s αL chain is CD11a, a different integrin from CD11c (αX, Itgax), the marker used to define these cells. See CD11c.

Key Points from Literature

Contradictions & Debates

None recorded — this is a single-source, murine finding with no counter-evidence and no human replication.

The relevant caution is scope, not conflict: all data are from mouse spleen after acute LCMV or influenza. Whether human DN2 cells are retained at a marginal-zone equivalent by the same integrins is untested. Human sampling in this wiki is almost entirely peripheral blood, which is precisely the compartment this mechanism would deplete.

VLA-4, S1PR3, CD11c, CXCR3, Follicular Exclusion, Atypical B Cell Effector Output, Age-Associated B Cell, DN2 B Cell

Sources